Proteome Sciences Eyes $8.3M Raise | GenomeWeb

NEW YORK (GenomeWeb News) – Proteome Sciences today announced a conditional placement of nearly 17.9 million new ordinary shares in order to raise £5 million ($8.3 million).

The UK-based firm said it has conditionally placed the shares of ₤.01 each to raise the funds with new and existing investors at ₤.28 per share. Proteome Sciences Chief Executive Christopher Pearce has subscribed for about 3.6 million shares at the placing price, and following the transaction he will hold 35.1 million, or a little more than 16 percent, of the firm's enlarged share capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.